XDEV.L vs. GENE.L

Last updated Jun 25, 2026

XDEV.L (Xtrackers MSCI World Value Factor UCITS ETF 1C) and GENE.L (UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc) are both Global Equities funds - XDEV.L tracks the MSCI ACWI Value NR USD while GENE.L tracks the MSCI ACWI NR USD. Both are passively managed. Over the past 5 years, XDEV.L returned 17.58%/yr vs 8.99%/yr for GENE.L. A 0.77 correlation means they provide meaningful diversification when combined. XDEV.L charges 0.25%/yr vs 0.20%/yr for GENE.L.

Performance

XDEV.L vs. GENE.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Xtrackers MSCI World Value Factor UCITS ETF 1C (XDEV.L) and UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc (GENE.L). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, XDEV.L achieves a 34.25% return, which is significantly higher than GENE.L's 6.51% return.

XDEV.L

• 1D: -0.63%
• 1M: 4.52%
• YTD: 34.25%
• 6M: 35.39%
• 1Y: 65.41%
• 3Y*: 27.29%
• 5Y*: 17.58%
• 10Y*: 13.24%

GENE.L

• 1D: 1.08%
• 1M: 2.36%
• YTD: 6.51%
• 6M: 6.80%
• 1Y: 19.74%
• 3Y*: 14.50%
• 5Y*: 8.99%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

XDEV.L vs. GENE.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
XDEV.L Xtrackers MSCI World Value Factor UCITS ETF 1C	34.25%	30.51%	6.79%	13.25%	1.01%	21.67%	-6.88%	14.56%	-9.23%	-0.12%
GENE.L UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc	6.51%	14.86%	10.70%	11.06%	-1.37%	17.63%	6.95%	21.36%	-26.44%	0.38%

Correlation

The correlation between XDEV.L and GENE.L is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.45
Correlation (3Y) Calculated over the trailing 3-year period	0.63
Correlation (5Y) Calculated over the trailing 5-year period	0.74
Correlation (All Time) Calculated using the full available price history since Dec 19, 2017	0.77

Over the past year, the correlation between XDEV.L and GENE.L has dropped to 0.45 - well below their long-term average of 0.77, suggesting their price drivers have been diverging.

XDEV.L vs. GENE.L - Sectors Allocation Comparison

Sectors	XDEV.L	GENE.L
Technology	41.7%	5.3%
Financial Services	13.3%	26.1%
Industrials	10.1%	5.6%
Healthcare	7.8%	13.2%
Consumer Cyclical	7.4%	11.5%
Communication Services	6.4%	7.6%
Consumer Defensive	3.9%	10.1%
Energy	3.1%	-
Basic Materials	2.7%	6.0%
Utilities	2.1%	8.0%
Real Estate	1.5%	6.6%

Return for Risk

XDEV.L vs. GENE.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XDEV.L

XDEV.L Risk / Return Rank: 97
XDEV.L Sharpe Ratio Rank: 98
XDEV.L Sortino Ratio Rank: 97
XDEV.L Omega Ratio Rank: 97
XDEV.L Calmar Ratio Rank: 97
XDEV.L Martin Ratio Rank: 97

GENE.L

GENE.L Risk / Return Rank: 65
GENE.L Sharpe Ratio Rank: 66
GENE.L Sortino Ratio Rank: 67
GENE.L Omega Ratio Rank: 62
GENE.L Calmar Ratio Rank: 67
GENE.L Martin Ratio Rank: 63

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XDEV.L vs. GENE.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI World Value Factor UCITS ETF 1C (XDEV.L) and UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc (GENE.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	XDEV.L	GENE.L	Difference
Sharpe ratio: Return per unit of total volatility	4.61	1.87	+2.74
Sortino ratio: Return per unit of downside risk	6.14	2.67	+3.47
Omega ratio: Gain probability vs. loss probability	1.86	1.33	+0.54
Calmar ratio: Return relative to maximum drawdown	9.41	2.90	+6.51
Martin ratio: Return relative to average drawdown	34.55	9.98	+24.57

XDEV.L vs. GENE.L - Sharpe Ratio Comparison

The current XDEV.L Sharpe Ratio is 4.61, which is higher than the GENE.L Sharpe Ratio of 1.87. The chart below compares the historical Sharpe Ratios of XDEV.L and GENE.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

XDEV.L vs. GENE.L - Drawdown Comparison

The maximum XDEV.L drawdown since its inception was -45.89%, which is greater than GENE.L's maximum drawdown of -36.84%. Use the drawdown chart below to compare losses from any high point for XDEV.L and GENE.L.

Drawdown Indicators

	XDEV.L	GENE.L	Difference
Max Drawdown Largest peak-to-trough decline	-45.89%	-36.84%	-9.05%
Max Drawdown (1Y) Largest decline over 1 year	-6.92%	-6.79%	-0.13%
Max Drawdown (3Y) Largest decline over 3 years	-19.90%	-19.69%	-0.21%
Max Drawdown (5Y) Largest decline over 5 years	-19.90%	-19.69%	-0.21%
Max Drawdown (10Y) Largest decline over 10 years	-35.20%	—	—
Current Drawdown Current decline from peak	-2.51%	0.00%	-2.51%
Average Drawdown Average peak-to-trough decline	-15.33%	-9.36%	-5.97%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.89%	1.97%	-0.08%

Volatility

XDEV.L vs. GENE.L - Volatility Comparison

Xtrackers MSCI World Value Factor UCITS ETF 1C (XDEV.L) has a higher volatility of 5.48% compared to UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc (GENE.L) at 2.29%. This indicates that XDEV.L's price experiences larger fluctuations and is considered to be riskier than GENE.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XDEV.L	GENE.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.48%	2.29%	+3.19%
Volatility (6M) Calculated over the trailing 6-month period	11.91%	7.70%	+4.21%
Volatility (1Y) Calculated over the trailing 1-year period	14.14%	10.55%	+3.59%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.99%	18.73%	+0.26%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	20.98%	19.48%	+1.50%

XDEV.L vs. GENE.L - Expense Ratio Comparison

XDEV.L has a 0.25% expense ratio, which is higher than GENE.L's 0.20% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.

Dividends

XDEV.L vs. GENE.L - Dividend Comparison

Neither XDEV.L nor GENE.L has paid dividends to shareholders.

Tickers have no history of dividend payments

Frequently Asked Questions

Can I hold both XDEV.L and GENE.L in my portfolio?

XDEV.L and GENE.L have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, XDEV.L or GENE.L?

On fees, GENE.L is cheaper at 0.20% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, XDEV.L or GENE.L?

GENE.L is cheaper with a 0.20% expense ratio, compared with 0.25% for XDEV.L.

What is the main difference between XDEV.L and GENE.L?

XDEV.L tracks MSCI ACWI Value NR USD, while GENE.L tracks MSCI ACWI NR USD. They also come from different issuers: DWS and UBS. Their fees differ too: 0.25% for XDEV.L and 0.20% for GENE.L.